Skip to main content

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Ethicon Physiomesh Lawsuits To Face Trial In April 2020

Introduction

The U.S District judge presiding in the Northern District of Georgia indicated that all federal Ethicon Physiomesh lawsuits will face their first bellwether trial involving the recalled hernia mesh in April 2020. 

As part of the bellwether process designed, it will help parties to gauge how jurors will respond to certain evidence and testimony, which is likely to be repeated throughout thousands of claims brought by the individuals.

Ethicon physiomesh is a multi-layered, flexible composite hernia mesh product introduced by J&J’s Ethicon subsidiary in 2010. Currently, there are more than 2,000 product liability lawsuits over Ethicon Physiomesh pending in the federal court system, each raising similar allegations that the drugmaker sold a defective and dangerous product which caused plaintiff with severe abdominal pain, infection, hernia recurrence, adhesions, perforations, erosion and other injuries associated with a hernia mesh failure.

The federal cases are centralized for pretrial proceedings before US District Judge Richard Story in the Northern District of Georgia as part of MDL. (MDL no. 2782), to avoid duplicative discovery, conflicting rulings from different courts and to serve the convenience of parties.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!